Use of CT and artificial intelligence in suspected or COVID-19 positive patients: statement of the Italian Society of Medical and Interventional Radiology

Emanuele Neri, Vittorio Miele, Francesca Coppola, Roberto Grassi, Emanuele Neri, Vittorio Miele, Francesca Coppola, Roberto Grassi

Abstract

The COVID-19 pandemic started in Italy in February 2020 with an exponential growth that has exceeded the number of cases reported in China. Italian radiology departments found themselves at the forefront in the management of suspected and positive COVID cases, both in diagnosis, in estimating the severity of the disease and in follow-up. In this context SIRM recommends chest X-ray as first-line imaging tool, CT as additional tool that shows typical features of COVID pneumonia, and ultrasound of the lungs as monitoring tool. SIRM recommends, as high priority, to ensure appropriate sanitation procedures on the scan equipment after detecting any suspected or positive COVID-19 patients. In this emergency situation, several expectations have been raised by the scientific community about the role that artificial intelligence can have in improving the diagnosis and treatment of coronavirus infection, and SIRM wishes to deliver clear statements to the radiological community, on the usefulness of artificial intelligence as a radiological decision support system in COVID-19 positive patients. (1) SIRM supports the research on the use of artificial intelligence as a predictive and prognostic decision support system, especially in hospitalized patients and those admitted to intensive care, and welcomes single center of multicenter studies for a clinical validation of the test. (2) SIRM does not support the use of CT with artificial intelligence for screening or as first-line test to diagnose COVID-19. (3) Chest CT with artificial intelligence cannot replace molecular diagnosis tests with nose-pharyngeal swab (rRT-PCR) in suspected for COVID-19 patients.

Keywords: Artificial intellingence; COVID-19; Computed tomography; Ethics; Imaging.

Conflict of interest statement

Authors declare that they have no conflict of interest.

References

    1. . Accessed 23 Apr 2020
    1. Guan WJ, Ni ZY, Hu Y, Liang WH, et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 doi: 10.1056/nejmoa2002032.
    1. Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020 doi: 10.1001/jama.2020.4344.
    1. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, Tao Q, Sun Z, Xia L. Correlation of chest CT and RT-PCR testing in Coronavirus Disease, 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020 doi: 10.1148/radiol.2020200642.
    1. Li Y, Xia L. Coronavirus Disease 2019 (COVID-19): role of chest CT in diagnosis and management. AJR Am J Roentgenol. 2020 doi: 10.2214/AJR.20.22954.
    1. Yuan M, Yin W, Tao Z, Tan W, Hu Y. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS ONE. 2020;15(3):e0230548. doi: 10.1371/journal.pone.0230548.
    1. . Accessed 23 Apr 2020
    1. . Accessed 23 Apr 2020 (document in italian)
    1. Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the clinical characteristics of Coronavirus Disease 2019 (COVID-19) J Gen Intern Med. 2020 doi: 10.1007/s11606-020-05762-w.
    1. Pontet J, Yic C, Díaz-Gómez JL, Rodriguez P, Sviridenko I, Méndez D, Noveri S, Soca A, Cancela M. Impact of an ultrasound-driven diagnostic protocol at early intensive-care stay: a randomized-controlled trial. Ultrasound J. 2019;11(1):24. doi: 10.1186/s13089-019-0139-2.
    1. Peng QY, Wang XT, Zhang LN, Chinese Critical Care Ultrasound Study Group (CCUSG) Findings of lung ultrasonography of novel coronavirus pneumonia during the 2019–2020 epidemic. Intensive Care Med. 2020 doi: 10.1007/s00134-020-05996-6.
    1. Kansagra AP, Yu JP, Chatterjee AR, Lenchik L, Chow DS, Prater AB, Yeh J, Doshi AM, Hawkins CM, Heilbrun ME, Smith SE, Oselkin M, Gupta P, Ali S. Big data and the future of radiology informatics. Acad Radiol. 2016;23(1):30–42. doi: 10.1016/j.acra.2015.10.004.
    1. Brink JA, Arenson RL, Grist TM, Lewin JS, Enzmann D. Bits and bytes: the future of radiology lies in informatics and information technology. Eur Radiol. 2017;27(9):3647–3651. doi: 10.1007/s00330-016-4688-5.
    1. European Society of Radiology (ESR) What the radiologist should know about artificial intelligence—an ESR white paper. Insights Imaging. 2019;10(1):44. doi: 10.1186/s13244-019-0738-2.
    1. Santosh KC. AI-driven tools for coronavirus outbreak: need of active learning and cross-population train/test models on multitudinal/multimodal data. J Med Syst. 2020;44(5):93. doi: 10.1007/s10916-020-01562-1.
    1. Li L, Qin L, Xu Z, et al. Artificial intelligence distinguishes COVID-19 from community acquired pneumonia on chest CT. Radiology. 2020 doi: 10.1148/radiol.2020200905.
    1. . Accessed 23 Apr 2020
    1. . Accessed 23 Apr 2020
    1. . Accessed 23 Apr 2020
    1. . Accessed 23 Apr 2020
    1. . Accessed 23 Apr 2020
    1. . Accessed 23 Apr 2020
    1. Neri E, Coppola F, Miele V, Bibbolino C, Grassi R. Artificial intelligence: who is responsible for the diagnosis? Radiol Med. 2020 doi: 10.1007/s11547-020-01135-9.
    1. Keskinbora KH. Medical ethics considerations on artificial intelligence. J Clin Neurosci. 2019;64:277–282. doi: 10.1016/j.jocn.2019.03.001.
    1. Geis JR, Brady A, Wu CC, et al. Ethics of artificial intelligence in radiology: summary of the joint European and North American multisociety statement. Insights Imaging. 2019;10(1):101. doi: 10.1186/s13244-019-0785-8.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren